Recce Pharmaceuticals (ASX:RCE) Secures A$30m Non-Dilutive Financing
Recce Pharmaceuticals (ASX:RCE) secures a A$30m debt facility with Avenue Capital Group to support Phase 3 trials.
Category: ASX-RCE
Recce Pharmaceuticals Ltd
Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Anti-Infectives
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.